focus -WSS

focus

author：hotspot 2025-09-30 17:17:13 - browse：79231

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： In Memoriam: Notable people who died in 2023
Next article： Study links childhood stress with decline in older age

hotspot

WSS

The cancer stories no one wants to hear

FDA's Woodcock to retire early next year

CRISPR pioneers react to Casgevy, first gene

Hospitals look to new technology to keep health care workers safe

CDC recommends RSV monoclonal antibody for infants

Biotech startup Celsius cuts 75% of staff ahead of first trial start

focus

focus

focus

Novavax promises a turnaround & Lilly roils the obesity market

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Guidelines to prevent youth baseball injuries need more muscle

A daunting task: navigating dual Medicare, Medicaid eligibility

Bright Health sells Medicare Advantage business to Molina

Study links childhood stress with decline in older age

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

PBM reforms clear House panel

Peter Hotez and the public health issue of online harassment

Physicians aren't 'burning out.' They're suffering from moral injury

explore

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Group behind ProMed defends move to subscription

How I helped Pfizer think through the ethics of Viagra

U.K. considers world's first use of meningitis vaccine to address gonorrhea

How I helped Pfizer think through the ethics of Viagra

FDA's Woodcock to retire early next year

Wikipedia

hotspot

hotspot

hotspot